Medical Innovation Acceleration Act of 2025

1. 01

   How would removing FDA oversight of noninvasive diagnostic devices affect patient safety and the ability to identify faulty or inaccurate devices?

2. 02

   What evidence exists that FDA regulation of these diagnostic tools creates enough burden to justify exempting them from safety review?

3. 03

   Which diagnostic device manufacturers would benefit most from this exemption, and how might competition change without regulatory standards?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.